Table 3.
Percentage of subjects with positive blockade titers before and after vaccination.
| Prevaccination % Positive | Postvaccination % Positive | |||||
|---|---|---|---|---|---|---|
| NOR-201 | NOR-210 | Both | NOR-201 | NOR-210 | Both | |
| GI.1 (1968) | 32 | 29 | 31 | 88 | 92 | 90 |
| GI.2 (2013) | 32 | 46 | 39 | 52 | 67 | 59 |
| GI.3 (2007) | 52 | 50 | 51 | 56 | 54 | 55 |
| GI.4 (2008) | 28 | 29 | 29 | 40 | 42 | 41 |
| GI.5 (2013) | 56 | 54 | 55 | 96 | 79 | 88 |
| GI.6 (2003) | 36 | 46 | 41 | 84 | 88 | 86 |
| GI.7 (2010) | 36 | 38 | 37 | 64 | 67 | 65 |
| GII.3 (2011) | 64 | 63 | 63 | 72 | 79 | 76 |
| GII.4 (CN) | 92 | 67 | 80 | 100 | 100 | 100 |
| GII.4 (2002) | 92 | 88 | 90 | 100 | 100 | 100 |
| GII.4 (2006a) | 92 | 88 | 90 | 100 | 100 | 100 |
| GII.4 (2006b) | 88 | 71 | 80 | 100 | 96 | 98 |
| GII.4 (2009) | 60 | 58 | 62 | 96 | 88 | 92 |
| GII.4 (2012) | 84 | 63 | 73 | 100 | 96 | 98 |
| GII.6 (2012) | 84 | 79 | 82 | 84 | 96 | 90 |
| GII.12 (2010) | 72 | 50 | 61 | 72 | 75 | 73 |
| GII.17 (1978) | 88 | 92 | 90 | 96 | 100 | 98 |
| GII.17 (2014) | 60 | 58 | 59 | 84 | 75 | 80 |
| GII.17 (2015) | 44 | 50 | 47 | 76 | 71 | 73 |
| GIV.1 (2012) | 4 | 13 | 8 | 12 | 17 | 14 |